NanoViricides is a development stage company creating a novel nanoviricide® class of drug candidates designed to specifically attack enveloped virus particles and to dismantle them. NNVC is developing drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. For more information visit the company’s Web site at www.nanoviricides.com

Let us hear your thoughts below: